International Clinical Trial: A single-center, single-arm clinical study of the efficacy and safety of Sacituzumab Tirumotecan in the treatment of locally advanced or metastatic SMARCA4-deleted non-small cell lung cancer that has failed first-line standard therapy

Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124895) titled 'A single-center, single-arm clinical study of the efficacy and safety of Sacituzumab Tirumotecan in the treatment of locally advanced or metastatic SMARCA4-deleted non-small cell lung cancer that has failed first-line standard therapy' on May 19.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Shanghai Pulmonary Hospital

Condition: SMARCA4-deleted advanced non-small cell lung cancer without sensitive gene mutations that failed front-line treatment

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-06-01

Target Sample Size: Treatment group:23;

Cou...